drugset / Press release
Phase 1 Data for Flotetuzumab, MacroGenics' CD123 x CD3 DART® Molecule, Presented at ESMO Congress 2017
2017-09-10 · MacroGenics · original macrogenics.com ↗
Phase 1 Data for Flotetuzumab, MacroGenics' CD123 x CD3 DART® Molecule, Presented at ESMO Congress 2017 19.5 KB
The release as fetched from its publisher. macrogenics.com ↗